Tom Templeman, the Senior Vice President, Integrated Supply Chain for Liquidia Technologies, participated in the Translational Nanomedicine Panel at the 2011 North Carolina Nanotechnology Commercialization Conference. He spoke about Liquidia’s recent launch of Phase 1 clinical trials for a flu vaccine candidate.
Video Rating: 0 / 5